Nanomedicines and Vaccines
NANO-VAC
Hospitais da Universidade de Coimbra
Coímbra, PortugalPublicaciones en colaboración con investigadores/as de Hospitais da Universidade de Coimbra (6)
2022
-
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1736-1750
2017
-
Expert opinion: Defining response to omalizumab in patients with chronic spontaneous urticaria
European Journal of Dermatology, Vol. 27, Núm. 5, pp. 455-463
2016
-
Basophil activation testing in diagnosis and monitoring of allergic disease - An overview
Allergo Journal, Vol. 25, Núm. 4, pp. 26-33
-
Basophil activation testing in diagnosis and monitoring of allergic disease – an overview
Allergo Journal International, Vol. 25, Núm. 4, pp. 106-113
2015
-
The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 70, Núm. 11, pp. 1393-1405
2012
-
Research needs in allergy: An EAACI position paper, in collaboration with EFA
Clinical and Translational Allergy, Vol. 2, Núm. 1